Klinogicare® Shockwave Storm Radial
Professional Radial Shockwave Therapy Device
- Adjustable pressure up to 7 bar and frequency range 1-21 Hz for precise treatment customization
- Extensive range of applicators designed to match specific anatomical zones and therapeutic goals - allowing the device to adapt to the clinician’s technique
- Contact radial shockwave technology ensuring accurate energy delivery and maximum control during treatment
Technology Background and Clinical Context
Radial shockwave therapy is primarily used for the treatment of superficial soft-tissue conditions, myofascial pain syndromes, and overload-related musculoskeletal disorders. Its clinical effectiveness has been well documented in the management of plantar fasciitis, tendinopathies, muscle injuries, and trigger points. At the same time, radial shockwave technology is not intended for deep tissue penetration or intra-articular pathologies.
Key technical consideration. Even at energy levels of 200 mJ, radial shockwave therapy remains a surface-oriented modality.
Radial shockwaves:
The fundamental physics of radial shockwave generation has remained essentially unchanged for over 20 years:
Practical differentiation between systems. As a result, the key differences between radial shockwave systems lie not in advertised pressure or energy values, but in:
Key technical consideration. Even at energy levels of 200 mJ, radial shockwave therapy remains a surface-oriented modality.
Radial shockwaves:
- disperse outward from the applicator,
- have no focal point,
- progressively lose energy with depth,
- and are clinically effective primarily within a 2–4 cm penetration range.
The fundamental physics of radial shockwave generation has remained essentially unchanged for over 20 years:
- pneumatic or electromagnetic energy generation,
- mechanical impact on the applicator,
- propagation of a dispersed radial wave.
Practical differentiation between systems. As a result, the key differences between radial shockwave systems lie not in advertised pressure or energy values, but in:
- pulse stability,
- durability of the impact mechanism,
- ease of use,
- and overall clinical versatility.
RSWT - Radial ShockWave Therapy. FSWT - Focused ShockWave Therapy.
Spatial-Average Temporal-Average Intensity:
Energy Flux Density:
Ultrasound consists of rapid oscillations (like sound waves) that act gently over a prolonged duration. This is why we measure the average power over a period of time. Ultrasound uses I-SATA because it is a continuous or pulsed "stream" of energy.
Shockwave (FSWT/RSWT) involves an instantaneous and powerful pulse. For this reason, it is more important to determine the energy density of that specific "impact" as it penetrates the tissues. Shockwaves use EFD because they are high-energy "events" or "shocks."
Spatial-Average Temporal-Average Intensity:
- Meaning: Ultrasound devices operate either continuously or in pulse mode. SATA represents the average ultrasound power, averaged over both the transducer's cross-sectional area and the total exposure time (including the "off" periods between pulses);
- Measurement Units: Watts per square centimeter (W/cm^2 or mW/cm^2).
- Purpose: This metric reflects the total thermal load on the tissues. It helps the clinician understand how much the target area will heat up during a prolonged treatment session.
Energy Flux Density:
- Meaning: Shockwave therapy is not just a vibration; it is a series of short, high-pressure "shocks" (pressure pulses). EFD indicates the amount of energy delivered to a single square millimeter of area at the focal point (the center) of the impact.
- Measurement Units: Millijoules per square millimeter (mJ/mm^2).,
- Low energy (<0.08\, mJ/mm^2): used for treating trigger points and tissue regeneration.
- Medium/High energy (>0.28\, mJ/mm^2): used for breaking down calcifications or treating bone-related issues.
Ultrasound consists of rapid oscillations (like sound waves) that act gently over a prolonged duration. This is why we measure the average power over a period of time. Ultrasound uses I-SATA because it is a continuous or pulsed "stream" of energy.
Shockwave (FSWT/RSWT) involves an instantaneous and powerful pulse. For this reason, it is more important to determine the energy density of that specific "impact" as it penetrates the tissues. Shockwaves use EFD because they are high-energy "events" or "shocks."
Technical and Clinical Considerations:
It is essential to clearly distinguish the capabilities and inherent limitations of radial shockwave therapy when evaluating its clinical applications.
An output level of 200 mJ in radial shockwave systems represents a relatively high value within this modality; however, it does not equate to the therapeutic characteristics of focused shockwave therapy. Radial shockwave therapy is primarily indicated for superficial soft-tissue conditions and myofascial disorders, whereas focused shockwave therapy is specifically designed to address deep tissue structures and intraosseous or orthopedic pathologies.
Physical Characteristics of Radial Shockwaves. Radial shockwaves are generated at the applicator tip and propagate into tissue as diverging pressure waves without a focal point. As a result, the energy density decreases rapidly with depth due to geometric dispersion and tissue attenuation. Even at higher nominal energy values (e.g., 200 mJ), the effective therapeutic depth of radial shockwaves is physiologically limited and typically does not exceed 2-4 cm, depending on tissue composition and treatment technique.
Limitations of Quantitative Output Parameters. Unlike focused shockwave systems, radial shockwave therapy lacks standardized, tissue-referenced metrics for energy delivery and clinical effectiveness:
Clinically Relevant Performance Parameters. Given these limitations, meaningful differentiation between radial shockwave systems should be based not on nominal output values but on operational and biomechanical performance characteristics that influence clinical outcomes.
Key parameters include:
Rather than emphasizing historical legacy or abstract performance claims, the presented systems are evaluated as practical clinical tools, designed to deliver repeatable and predictable therapeutic effects under routine clinical conditions.
An output level of 200 mJ in radial shockwave systems represents a relatively high value within this modality; however, it does not equate to the therapeutic characteristics of focused shockwave therapy. Radial shockwave therapy is primarily indicated for superficial soft-tissue conditions and myofascial disorders, whereas focused shockwave therapy is specifically designed to address deep tissue structures and intraosseous or orthopedic pathologies.
Physical Characteristics of Radial Shockwaves. Radial shockwaves are generated at the applicator tip and propagate into tissue as diverging pressure waves without a focal point. As a result, the energy density decreases rapidly with depth due to geometric dispersion and tissue attenuation. Even at higher nominal energy values (e.g., 200 mJ), the effective therapeutic depth of radial shockwaves is physiologically limited and typically does not exceed 2-4 cm, depending on tissue composition and treatment technique.
Limitations of Quantitative Output Parameters. Unlike focused shockwave systems, radial shockwave therapy lacks standardized, tissue-referenced metrics for energy delivery and clinical effectiveness:
- Bar values represent pneumatic system pressure and do not directly correspond to energy deposition in biological tissue
- mJ values describe mechanical impact energy at the applicator, without accounting for dispersion and tissue losses
- Hz reflects pulse repetition frequency rather than therapeutic efficacy
Clinically Relevant Performance Parameters. Given these limitations, meaningful differentiation between radial shockwave systems should be based not on nominal output values but on operational and biomechanical performance characteristics that influence clinical outcomes.
Key parameters include:
- Pulse-to-pulse energy stability across extended treatment sessions
- Durability of the impact generation mechanism and maintenance of output consistency over time
- Applicator geometry and diameter, influencing surface energy distribution and pressure gradients
- Energy coupling efficiency at the tissue interface and attenuation behavior within superficial layers
- Reproducibility of the effective penetration depth under clinical conditions
Rather than emphasizing historical legacy or abstract performance claims, the presented systems are evaluated as practical clinical tools, designed to deliver repeatable and predictable therapeutic effects under routine clinical conditions.
Description
Klinogicare® Shockwave Storm Radial is a portable radial shockwave therapy system designed for controlled stimulation of superficial soft tissues. The device delivers acoustic pressure waves with adjustable parameters, enabling consistent volumetric tissue interaction across a defined treatment area. Interchangeable applicators of different shapes and diameters allow adaptation to various anatomical regions and clinical indications.
Operating principle
The system generates radial shockwaves through an accelerated projectile mechanism inside the applicator. The resulting mechanical pressure wave propagates radially into the tissues, leading to mechanical stimulation that supports local microcirculation, modulates nociceptive signaling, and facilitates soft tissue recovery processes.
Treatment protocol
Clinical practice shows that measurable improvement is commonly observed after 3–4 treatment sessions performed at weekly intervals. A typical session duration is approximately 10 minutes, allowing standardized and time-efficient therapy delivery.
Clinical characteristics
Adjustable pressure and frequency parameters (0.5–7 bar, 1–21 Hz) enable controlled application for both acute and chronic soft tissue conditions. The system provides reproducible output, supporting predictable clinical responses when used with appropriate technique and parameter selection.
Patient tolerance
Radial shockwave therapy is non-invasive and generally well tolerated. Transient local reactions such as mild discomfort or erythema may occur, without functional limitations or recovery time.
Operating principle
The system generates radial shockwaves through an accelerated projectile mechanism inside the applicator. The resulting mechanical pressure wave propagates radially into the tissues, leading to mechanical stimulation that supports local microcirculation, modulates nociceptive signaling, and facilitates soft tissue recovery processes.
Treatment protocol
Clinical practice shows that measurable improvement is commonly observed after 3–4 treatment sessions performed at weekly intervals. A typical session duration is approximately 10 minutes, allowing standardized and time-efficient therapy delivery.
Clinical characteristics
Adjustable pressure and frequency parameters (0.5–7 bar, 1–21 Hz) enable controlled application for both acute and chronic soft tissue conditions. The system provides reproducible output, supporting predictable clinical responses when used with appropriate technique and parameter selection.
Patient tolerance
Radial shockwave therapy is non-invasive and generally well tolerated. Transient local reactions such as mild discomfort or erythema may occur, without functional limitations or recovery time.
Thoughtful configuration
The system is supplied with 13 applicators, grouped according to clinical tasks:
Different applicator shapes and diameters allow energy to be focused on localized structures (trigger points, tendon insertions) or efficiently distributed across larger areas such as major muscle groups and fascial chains.
Practical usability
Applicator selection and protocol recommendations are integrated into the system interface. This simplifies parameter setup, reduces preparation time, and minimizes the risk of operator error during treatment.
Non-invasive and clinically established
Radial shockwave therapy is applied externally, without injections or anesthesia, making it a safe and widely accepted option for the management of various musculoskeletal and myofascial pain conditions.
Therapeutic mechanism
The mechanical action of radial shockwaves stimulates tissue recovery processes, improves local circulation, reduces pain sensitivity, and supports regeneration in subacute and chronic conditions.
Minimal recovery time
No post-procedure downtime is required. In most cases, patients can immediately return to normal daily activities.
Safety controlAdjustable energy and frequency settings allow precise dosing of treatment intensity according to clinical indications and individual patient tolerance. Contraindications should be assessed and established clinical guidelines followed prior to therapy.
The system is supplied with 13 applicators, grouped according to clinical tasks:
- 6 applicators for pain-related conditions
- 3 applicators optimized for paravertebral and spinal-adjacent areas
- 4 applicators designed for fascial and myofascial therapy
Different applicator shapes and diameters allow energy to be focused on localized structures (trigger points, tendon insertions) or efficiently distributed across larger areas such as major muscle groups and fascial chains.
Practical usability
Applicator selection and protocol recommendations are integrated into the system interface. This simplifies parameter setup, reduces preparation time, and minimizes the risk of operator error during treatment.
Non-invasive and clinically established
Radial shockwave therapy is applied externally, without injections or anesthesia, making it a safe and widely accepted option for the management of various musculoskeletal and myofascial pain conditions.
Therapeutic mechanism
The mechanical action of radial shockwaves stimulates tissue recovery processes, improves local circulation, reduces pain sensitivity, and supports regeneration in subacute and chronic conditions.
Minimal recovery time
No post-procedure downtime is required. In most cases, patients can immediately return to normal daily activities.
Safety controlAdjustable energy and frequency settings allow precise dosing of treatment intensity according to clinical indications and individual patient tolerance. Contraindications should be assessed and established clinical guidelines followed prior to therapy.
Technical Specifications
- Technology: Radial acoustic shockwave therapy
- Output energy: Up to 200 mJ (equivalent to up to 7 bar)
- Operating frequency: 1-21 Hz, adjustable
- Operating modes: Manual, automatic, user-defined protocols
- Pulse delivery modes: 4 modes (continuous / burst 4 / burst 8 / burst 12)
- Applicators: 13 applicators of various shapes and diameters for different anatomical areas
- Control interface: 10-inch touchscreen display
- Power supply: 100-240 V, 50/60 Hz
- Shockwave generation principle: Electromagnetic
- Dimensions: 44 x 31 x 22 cm
- Weight: 10 kg
- Included: Wheeled flight case for transport and storage
All technical and functional parameters are identical across all versions.
»
Scientific Background and Evidence
Extracorporeal Shockwave Therapy in the Management of Sports Medicine Injuries
Allison N Schroeder, Adam S Tenforde, Elena J Jelsing.
Volume 20(6):p 298-305, June 2021, https://doi.org/10.1249/jsr.0000000000000851
Copyright © 2021 by the American College of Sports Medicine.
Volume 20(6):p 298-305, June 2021, https://doi.org/10.1249/jsr.0000000000000851
Copyright © 2021 by the American College of Sports Medicine.
Abstract
Treatment of musculoskeletal conditions in athletes with extracorporeal shockwave therapy (ESWT) is gaining popularity as greater evidence supports its use. ESWT protocols (describing energy flux density, number of impulses, type of shockwave (focused or radial), number/frequency/duration of treatment session, area of application, and postprocedural therapy protocols) can be adjusted in the clinical setting. Protocols vary across studies, and optimal protocols for most indications are yet to be determined.
ESWT can safely be used to treat various musculoskeletal conditions in athletes, including rotator cuff tendinopathy, lateral elbow epicondlyopathy, greater trochanteric pain syndrome, hamstring tendinopathy, patellar tendinopathy, Achilles tendinopathy, other tendinopathies, plantar fasciopathy, bone stress injuries, and medial tibial stress syndrome. ESWT can be used to treat in-season athletes, as it often requires no/minimal time away from sport and may result in rapid benefits. ESWT should be used in conjunction with physical therapy to facilitate longer-term gains in function and to optimize healing.
ESWT can safely be used to treat various musculoskeletal conditions in athletes, including rotator cuff tendinopathy, lateral elbow epicondlyopathy, greater trochanteric pain syndrome, hamstring tendinopathy, patellar tendinopathy, Achilles tendinopathy, other tendinopathies, plantar fasciopathy, bone stress injuries, and medial tibial stress syndrome. ESWT can be used to treat in-season athletes, as it often requires no/minimal time away from sport and may result in rapid benefits. ESWT should be used in conjunction with physical therapy to facilitate longer-term gains in function and to optimize healing.
»
Exercise, radial pressure waves, and photobiomodulation for management of non-insertional Achilles tendinopathy in runners: a three-arm non-blinded randomised control trial
BMJ Journals (British Association of Sport and Exercise Medicine) Volume 11, Issue 4 , Published: 2025 Oct 5;11(4):e002442
DOI: 10.1136/bmjsem-2024-002442
Авторы: Adam S. Tenforde, Linh Pham, Logan Walter Gaudette, Margaret M. Funk, Katie El Vogel, Michelle M. Bruneau, Xiaoning Yuan, Jeremy D. Schroeder, Brad Isaacson, Nelson Hagar, Elizabeth Metzger, David C. Nolan, Joshua Tam, Karin Gravare Silbernagel
DOI: 10.1136/bmjsem-2024-002442
Авторы: Adam S. Tenforde, Linh Pham, Logan Walter Gaudette, Margaret M. Funk, Katie El Vogel, Michelle M. Bruneau, Xiaoning Yuan, Jeremy D. Schroeder, Brad Isaacson, Nelson Hagar, Elizabeth Metzger, David C. Nolan, Joshua Tam, Karin Gravare Silbernagel
Abstract
Abstract
Objectives: Non-insertional Achilles tendinopathy (AT) is a common running injury. Exercise loading programme (EXER) is the primary treatment. Other options include radial pressure wave (RPW, commonly referred to as shockwave) and photobiomodulation therapy (PBMT). We hypothesised that EXER+RPW and EXER+RPW+PBMT would result in greater reduction in symptoms measured using the eight-item Victorian Institute of Sports Assessment-Achilles (VISA-A) and greater improvement in functional outcomes compared with EXER. A secondary aim was to explore outcomes using elective treatment for three additional months.
Methods: Runners with AT and symptoms exceeding 3 months were randomised to EXER, EXER+RPW or EXER+RPW+ PBMT. RPW was delivered once weekly for three treatments. Those assigned to receive PBMT additionally received treatment two times a week for 3 weeks. VISA-A, University of Wisconsin Running Injury and Recovery Index and Patient-Reported Outcomes Measurement Information System 29-item were obtained at baseline and intervals over 3 months. Afterwards, runners could elect to receive a different treatment for three additional months.
Results: Forty-six runners enrolled (24 males, 22 females; average age±SD:40±12 years). Runners assigned EXER+RPW had a greater improvement than EXER at 3 months in VISA-A (mean 33 vs 18 points, p=0.023; 95% CI 28.4 to 2.4), and no differences were detected between EXER+RPW+ PBMT and EXER (25 vs 18 points, p=0.12; 95% CI 25.9 to -10.8). There were greater improvements in running index measures, pain interference and social roles in EXER+RPW compared with EXER. VISA-A increased over 3 month crossover to EXER+RPW and EXER+RPW+PBMT (11 points, both p<0.05 compared with EXER).
Discussion: Combined EXER and RPW had the largest measured reduction in symptoms at 3 months. However, all groups met clinical improvement, highlighting the importance of EXER. Larger studies in other physically active populations may clarify clinical benefits of each treatment.
Objectives: Non-insertional Achilles tendinopathy (AT) is a common running injury. Exercise loading programme (EXER) is the primary treatment. Other options include radial pressure wave (RPW, commonly referred to as shockwave) and photobiomodulation therapy (PBMT). We hypothesised that EXER+RPW and EXER+RPW+PBMT would result in greater reduction in symptoms measured using the eight-item Victorian Institute of Sports Assessment-Achilles (VISA-A) and greater improvement in functional outcomes compared with EXER. A secondary aim was to explore outcomes using elective treatment for three additional months.
Methods: Runners with AT and symptoms exceeding 3 months were randomised to EXER, EXER+RPW or EXER+RPW+ PBMT. RPW was delivered once weekly for three treatments. Those assigned to receive PBMT additionally received treatment two times a week for 3 weeks. VISA-A, University of Wisconsin Running Injury and Recovery Index and Patient-Reported Outcomes Measurement Information System 29-item were obtained at baseline and intervals over 3 months. Afterwards, runners could elect to receive a different treatment for three additional months.
Results: Forty-six runners enrolled (24 males, 22 females; average age±SD:40±12 years). Runners assigned EXER+RPW had a greater improvement than EXER at 3 months in VISA-A (mean 33 vs 18 points, p=0.023; 95% CI 28.4 to 2.4), and no differences were detected between EXER+RPW+ PBMT and EXER (25 vs 18 points, p=0.12; 95% CI 25.9 to -10.8). There were greater improvements in running index measures, pain interference and social roles in EXER+RPW compared with EXER. VISA-A increased over 3 month crossover to EXER+RPW and EXER+RPW+PBMT (11 points, both p<0.05 compared with EXER).
Discussion: Combined EXER and RPW had the largest measured reduction in symptoms at 3 months. However, all groups met clinical improvement, highlighting the importance of EXER. Larger studies in other physically active populations may clarify clinical benefits of each treatment.
»
Return to play after treating acute muscle injuries in elite football players with radial extracorporeal shock wave therapy
James P. M. Morgan, Mario Hamm, Christoph Schmitz, Matthias H. Brem. Journal of Orthopaedic Surgery and Research, Dec.07, 2021 Volume 16, article 708. DOI: 10.1186/s13018-021-02853-0
Abstract
All players were male, aged between 18 and 35 years. They were professional football players competing in the first and second German Bundesliga.
Background:
To compare lay-off times achieved by treating acute muscle injuries in elite football players with a multimodal therapy approach that includes a specific protocol of almost daily radial extracorporeal shock wave therapy (rESWT) with corresponding data reported in the literature.
Methods:
We performed a retrospective analysis of treatments and recovery times of muscle injuries suffered by the players of an elite football team competing in the first/second German Bundesliga during one of the previous seasons.
Results:
A total of 20 acute muscle injuries were diagnosed and treated in the aforementioned season, of which eight (40%) were diagnosed as Type 1a/muscular tightness injuries, five (25%) as Type 2b/muscle strain injuries, four (20%) as Type 3a/partial muscle tear injuries and three (15%) as contusions. All injuries were treated with the previously mentioned multimodal therapy approach. Compared with data reported by Ekstrand et al. (Br J Sports Med 47:769-774, 2013), lay-off times (median/mean) were shortened by 54% and 58%, respectively, in the case of Type 1a injuries, by 50% and 55%, respectively, in the case of Type 2b injuries as well as by 8% and 21%, respectively, in the case of Type 3a injuries. No adverse reactions were observed.
Conclusions:
Overall, the multimodal therapy approach investigated in this study is a safe and effective treatment approach for treating Type 1a and 2b acute muscle injuries amongst elite football players and may help to prevent more severe, structural muscle injuries.
Background:
To compare lay-off times achieved by treating acute muscle injuries in elite football players with a multimodal therapy approach that includes a specific protocol of almost daily radial extracorporeal shock wave therapy (rESWT) with corresponding data reported in the literature.
Methods:
We performed a retrospective analysis of treatments and recovery times of muscle injuries suffered by the players of an elite football team competing in the first/second German Bundesliga during one of the previous seasons.
Results:
A total of 20 acute muscle injuries were diagnosed and treated in the aforementioned season, of which eight (40%) were diagnosed as Type 1a/muscular tightness injuries, five (25%) as Type 2b/muscle strain injuries, four (20%) as Type 3a/partial muscle tear injuries and three (15%) as contusions. All injuries were treated with the previously mentioned multimodal therapy approach. Compared with data reported by Ekstrand et al. (Br J Sports Med 47:769-774, 2013), lay-off times (median/mean) were shortened by 54% and 58%, respectively, in the case of Type 1a injuries, by 50% and 55%, respectively, in the case of Type 2b injuries as well as by 8% and 21%, respectively, in the case of Type 3a injuries. No adverse reactions were observed.
Conclusions:
Overall, the multimodal therapy approach investigated in this study is a safe and effective treatment approach for treating Type 1a and 2b acute muscle injuries amongst elite football players and may help to prevent more severe, structural muscle injuries.
»
Manufacturer:
Manufacturer:
Copyright © 2014–2025 Gatria Global LLC. 66 W Flagler Street, Miami, 33130, Florida, USA.
US TAX ID EIN 35-2691088
EU GERMAN TAX ID Steuernummer 205/5975/4705 VBZ 83
Contact us now
And we will get back to you shortly
By submitting a request, you consent to the processing of your data in accordance with the laws of your country. We do not use cookies. We do not store or sell any data to third-party companies.